Outcome measure | Adjunctive OMIs used to measures this across the trials |
---|---|
Patient history of CRS: nasal blockage/congestion, nasal discharge, olfactory disturbance, facial pressure or pain, headache | Visual Analogue Scale (VAS) – multiple variations, SNOT-20, modified RSDI, SNOT-22, RSOM-31, Chronic Sinusitis Survey, SNAQ-11 |
Overall discomfort | SNOT-20, Short-form-36 (SF-36) |
Adjunctive symptoms of sneezing, itching, cough, Eustachian tube discomfort, dizziness, otalgia | SNOT-20, SNOT-22 |
Impact on quality of life with inclusion of mental health, sleep disruption, fatigue, productivity, concentration | SNOT-20, SNOT-22, SF-36, Short-form-12 (SF-12) |
Nasal swelling and local or systemic inflammation | Acoustic rhinomanometry, nitric oxide (NO), peak nasal inspiratory flow (PNIF), nasal mucosal eosinophilia on nasal smear or biopsy, intranasal inflammatory markers such as interleukins, serum inflammatory markers including WCC and differential, ESR, CRP, serum immunoglobulins with emphasis on IgE, skin-prick testing and serum RAST testing |
Altered mucociliary function | Saccharine clearance test |
Surgical and medical complications | Patient history, patient diary, blood tests for steroid-induced side effects, ocular assessments including slit-lamp examination, tonometry studies, visual acuity, colour vision charts, oral swabs for candidiasis |
Intranasal polyps, discharge, oedema, adhesions, crusting | Anterior rhinoscopy, nasal endoscopy, polyp histology |
Treatment compliance, adjunctive use of rescue medication, comfort of treatment | Patient diary, history, number of bottles or volume of spray/inhaler used, number of empty douche bottles |
Extent of sinonasal disease | Nasal endoscopy, CT scan (Lund-Mackay or Catalano and Payne modification of the frontal recess), plain sinus X-ray, MRI |
Presence of intranasal bacteria and fungi | Swab/secretion microscopy and culture, intranasal fungal protein (Alternaria) levels |
Impact on asthma | History, global initiative for asthma guidelines, patient diary, VAS, peak expiratory flow rate, FEV1, pulmonary function tests, exhaled respiratory NO |
Olfaction | History, VAS, SNOT-20, SNOT-22, butanol threshold test, University of Pennsylvania Smell Identification Test (UPSIT), coffee turpentine and lavender oil smell assessment on a scale of 0–3, oflactometry, Sniffin Sticks |
Length of improvement with treatment | X-rays, history |